"The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the p"...
DOSAGE AND ADMINISTRATION
For intramuscular injection only.
Dosage And Schedule
The dose and schedule for FLUARIX are presented in Table 1.
Table 1: FLUARIX: Dosing
|Age||Vaccination Status||Dose and Schedule|
|3 through 8 years of age||Not previously vaccinated with influenza vaccine||Two doses (0.5-mL each) at least 4 weeks apart|
|Vaccinated with influenza vaccine in a previous season||One or two dosesa (0.5-mL each)|
|9 years of age and older||Not applicable||One 0.5-mL dose|
|a One dose or two doses (0.5-mL each) depending on vaccination history as per the annual Advisory Committee on Immunization Practices (ACIP) recommendation on prevention and control of influenza with vaccines. If two doses, administer each 0.5-mL dose at least 4 weeks apart.|
Shake well before administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered.
Attach a sterile needle to the prefilled syringe and administer intramuscularly.
Do not administer this product intravenously, intradermally, or subcutaneously.
Dosage Forms And Strengths
FLUARIX is a suspension for injection. Each 0.5-mL dose is supplied in single-dose prefilled TIP-LOK® syringes.
Storage And Handling
FLUARIX is supplied in 0.5-mL single-dose prefilled TIP-LOK syringes (packaged without needles).
NDC 58160-881-41 Syringe in Package of 10: NDC 58160-881-52
Store refrigerated between 2° and 8°C (36° and 46°F). Do not freeze. Discard if the vaccine has been frozen. Store in the original package to protect from light.
Manufactured by GlaxoSmithKline Biologicals, Dresden, Germany, a branch of SmithKline Beecham Pharma GmbH & Co. KG, Munich, Germany Licensed by GlaxoSmithKline Biologicals, Rixensart, Belgium, US License 1617. Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/8/2014
Additional Fluarix Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.